Navigation Links
Antares Pharma Announces Positive Results from Application Site,Study for Anturol

ortly."

ANTUROL(R) ATD(TM) transdermal gel is intended to treat symptoms of overactive bladder (OAB), a lower urinary tract disorder resulting in a symptom syndrome including urgency with (OAB wet) or without (OAB dry) urge incontinence, usually with frequency and/or nocturia. OAB is estimated to affect more than more than 33 million people in the United States , and more than 22 million people in Europe. While OAB can affect a person at any age, it is most common among the elderly, with a prevalence of 33% to 61% in people over age 65. Despite its rising prevalence with age, OAB is treatable at every age. In recent published reports the market is described as one of the fastest-growing sectors in the pharmaceutical industry is and projected to exceed approximately $ 4 billion by 2010.

About Antares Pharma

Antares Pharma is a specialized pharma product development company focused on developing patented drug delivery systems and injectable device engineering capabilities. Antares' current technology platforms include its ATD(TM) Advanced Transdermal Delivery system, and its related TecTix(TM) system for topical and transmucosal delivery, its Easy Tec(TM) oral fast-melt technology, and subcutaneous injection technology platforms including both Vibex(TM) disposable mini-needle injection device and Valeo(TM)/Vision(R) reusable needle-free injection devices. Antares Pharma is committed to leveraging its multiple drug delivery platforms to add value to existing drugs and to create new pharmaceutical products and injectable devices. Overall, Antares' product pipeline, if approved, will address unmet medical needs by reducing side effect profiles, improving safety, increasing effectiveness, and improving patient compliance and convenience. Antares Pharma has corporate headquarters in Princeton Crossroads Corporate Center in Ewing, NJ, with subsidiaries performing research, development, manufacturing and product commercialization activities in Minneapoli
'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

Post Your Comments:
(Date:12/1/2009)... , NEW YORK, Dec. 1 Repor...eport is available in its catalogue: ,, The Fu...o 2015, Competitive Benchmarking, Product Pipeline...r.com/p0166817/The-Future-of-Oncology-Therapeutics...ng-Product-Pipeline-and-Deals-Analysis.html ,,...
(Date:12/1/2009)... , Radiologist reports 90 percent radiation red...PRNewswire-USNewswire/ -- Dr. James Earls, a radio...burban Washington, D.C. will present the findings ...e amount of radiation heart patients received from...o. ,, Dr. Earls will present the study to the...
(Date:12/1/2009)... , CHERRY HILL, N.J., Dec. 1 /PRN...n Francis Bodine was surprised and delighted when ...ancer went from about 20 minutes each day to less ..., doctors at the Delaware Valley Urology Cancer C...; radiotherapy technology from Varian Medical Sys...
Breaking Medicine Technology:Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Radiation Reduction in Heart CT Scans Reported in Study 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Spatial Integrated Systems Inc Files Patent Application 10210 1Spatial Integrated Systems Inc Files Patent Application 10210 2Wrist fracture patients less likely to be evaluated for osteoporosis 58645 1Wrist fracture patients less likely to be evaluated for osteoporosis 58645 2Blood diagnosis chip based and mobile 58640 1Blood diagnosis chip based and mobile 58640 2
(Date:12/1/2009)...velopment of simple screening test, expert says ,... a finding that could lead to a simple blood test ...dentified immune system markers that indicate earl...g cancer. , The researchers examined gene expre...ith non-small cell lung cancer and a control group...
(Date:12/1/2009)...would benefit from liver surgery after chemo, stud... News) -- A CT scan of liver tumors caused by the ...ll survival after chemotherapy, researchers report...hemotherapy has been shown to improve survival in ...produce better results in patients having surgery ...
(Date:12/1/2009)...n because pandemic,s course remains unpredictable ...A U.S. health official said Tuesday that H1N1 swin...ly, but many experts agreed the virus could return...idespread in 32 states -- down from 43 states the ...e U.S. Centers for Disease Control and Prevention ...
(Date:12/1/2009)..., 2009)The Clinical Research Building (CRB), at th...as been honored for its sustainability components....tablished by the U.S. Green Building Council and v...ute (GBCI). LEED is the nation,s preeminent progra...een buildings., "Having a LEED certified building...
(Date:12/1/2009)... Ever thought you could quit smoking while you,re ...roundbreaking new system for quitting is easy, pai...enty eight days your cravings and desire to smoke ... (PRWEB) December 1, 2009 -- Izabella had tried...iction to nicotine, smoking at least a pack a day....
Breaking Medicine News(10 mins):Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:CT Scan May Predict Colon Cancer Survival 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3
...achytherapy, intensity-modulated radiotherapy (IMR...dy radiotherapy (SBRT) , , PALO ALTO, Calif., Apr...showcase the company,s full spectrum of prostate c...n offers state-of-the-art technology for all five ...
...n goes undetected until rupture , , FRIDAY...at risk of an abdominal aortic aneurysm are gettin...An abdominal aortic aneurysm is a weak area in the...rtic aneurysms initially have no symptoms but can ...
...a erases the advantage, study finds, , , F... in the armed forces tend to be in better health t...xperienced combat duty, that initial health advant...ed Friday at the American Heart Association,s 10th...
...the role of prostaglandins a family of fatty comp...ressure maintenance, researchers at the University... discovered that mice that lack the receptor for o...ole for the type of prostaglandin studied, PG F2-a...
... and Mid-Sized Drug Companies to Adopt "Smart" Dru...O, Calif., April 24 /PRNewswire-FirstCall/ -- ... third party logistics provider Golden State Medic...tions in advance of state and federal mandates. ,...
...s to Medigap Secondary Insurance for Florida,s Mos...a., April 24 The Florida Legislature voted today ...l population of Florida,s kidney failure patients ...d for this legislation. , , Mourning, who is also...
Other Medicine News:Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 2Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 3Health News:Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Technologies at the American Urological Association Meeting in Chicago 4Health News:Too Few Screened for Abdominal Aneurysm, Study Says 2Health News:Combat Duty Harms Long-Term Health of Vets 2Health News:Combat Duty Harms Long-Term Health of Vets 3Health News:New target for maintaining healthy blood pressure discovered 2Health News:New target for maintaining healthy blood pressure discovered 3Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 2Health News:IBM and Golden State Medical Supply Create Drug Safety Model to Help Combat Counterfeiting 3Health News:Florida Legislature Renames Proposed Bill to Help State's Kidney Failure Patients "The Alonzo Mourning Access to Care Act" 2
CA-1000 (220V/50Hz)
...que DNA sequencing reagents including linear poly...istry and cyanine-based infrared dyes- coupled wit...ction, ore meaningful raw data, and higher-quality...0 to resolve complex sequences, filling in the gap...
ABL555 Blood gas analyzer
Rapidlink Critical Care Information Management System
Medicine Products: